Tirzepatide
Used as part of an individualized metabolic plan based on goals, health history, safety considerations, tolerance, and long-term strategy.
Back to peptide library
Dual GIP / GLP-1 metabolic support
Tirzepatide
A powerful two-pathway metabolic option for appetite control, fullness, cravings, blood-sugar balance, body-composition change, and long-term metabolic health.
GIP + GLP-1 activityWeekly injectable optionsOral tablet options reviewedMD eligibility review
Overview
What is Tirzepatide?
Tirzepatide is a first-in-class dual GIP and GLP-1 receptor agonist, meaning it activates two incretin pathways involved in appetite regulation, fullness, blood-sugar balance, and metabolic signaling.
Unlike single-pathway GLP-1 medications, tirzepatide works through two hormone pathways at the same time. This dual mechanism supports stronger appetite control, greater satiety, improved glucose regulation, and significant body-composition change when paired with nutrition, activity, and medical oversight.
In the SURMOUNT-1 clinical trial, participants using the highest studied dose achieved an average 22.5% body-weight reduction over 72 weeks. At IPS, Tirzepatide is used inside a complete metabolic plan that includes consultation, safety screening, goal setting, dose progression, nutrition, protein intake, resistance training, side-effect management, and long-term maintenance planning.
Common program goals
- Reduce appetite and food noise
- Support clinically guided body-composition change
- Improve adherence to nutrition targets
- Support glucose and metabolic-health markers
- Build a maintenance plan for after active weight loss
Who it may fit
Clinical tirzepatide considerations.
Tirzepatide Tablets
Tablet options are discussed separately when they fit the patient, clinical goal, and overall plan.
Metabolic plan fit
Tirzepatide works best as part of a complete metabolic plan that includes nutrition, protein intake, resistance training, lab markers, tolerance, side-effect management, dose progression, and maintenance planning.
How It Works
How tirzepatide may support weight management.
Tirzepatide may help support appetite, fullness, cravings, and blood-sugar balance through two incretin-related pathways.
GIP receptor activity
GIP signaling is involved in insulin response and metabolic regulation, and may complement GLP-1 activity.
GLP-1 receptor activity
GLP-1 pathways can influence appetite, satiety, gastric emptying, and glucose-dependent insulin signaling.
Metabolic support
This program is considered when weight-management goals overlap with appetite, cravings, and blood-sugar support.
Maintenance planning
IPS pairs medication reviews with nutrition structure, protein targets, resistance training, and follow-up.
Process
How tirzepatide care works at IPS.
Consultation
Review goals, weight history, medications, contraindications, training, nutrition, and prior GLP-1 or incretin experience.
Baseline Review
Labs and history help determine whether tirzepatide is reasonable and what monitoring is appropriate.
Titration Plan
If appropriate, the plan is adjusted gradually to balance response, side effects, nutrition intake, and clinical goals.
Ongoing Support
Follow-up focuses on progress, tolerance, hydration, protein intake, lean-mass protection, and maintenance strategy.
Clinical Fit
Tirzepatide is a stronger metabolic strategy.
Tirzepatide is for patients who want a stronger metabolic strategy — not another diet plan, appetite hack, or short-term weight-loss attempt. IPS evaluates Tirzepatide for patients focused on appetite control, food noise, cravings, fullness, blood-sugar balance, body-composition change, and long-term metabolic improvement.
Unlike single-pathway GLP-1 options, Tirzepatide works through GIP + GLP-1 pathways, giving it a more advanced metabolic profile for patients who need deeper appetite and body-composition support.
Dual-Pathway SupportTirzepatide targets two incretin pathways involved in appetite regulation, fullness, glucose handling, cravings, and metabolic signaling.
Food Noise + CravingsFor many patients, the biggest issue is not willpower — it is constant hunger, cravings, and food noise. Tirzepatide is used to help quiet that drive while building a more sustainable plan.
Body-Composition StrategyIPS pairs Tirzepatide with protein targets, hydration, movement, resistance training, and follow-up so weight loss is not random medication-only weight reduction.
Tolerance + Dose ProgressionThe plan is built around response. IPS reviews appetite change, digestion, energy, hydration, nutrition intake, side effects, and whether the pace makes sense.
Medical History ReviewCurrent medications, prior GLP-1/GIP experience, digestive history, gallbladder history, pancreatitis risk, thyroid/MEN2 history, pregnancy-related factors where applicable, and overall fit are reviewed before moving forward.
Personalized ResultsThe strongest results come from medication, nutrition, movement, sleep, consistency, dose strategy, and follow-up working together.
Questions
Frequently asked.
How is tirzepatide different from semaglutide?
Semaglutide works primarily through GLP-1 receptor activity. Tirzepatide works through both GIP and GLP-1 pathways. Option selection is based on medical history, goals, tolerance, and clinical context.
How often is it usually taken?
Injectable tirzepatide protocols are commonly weekly, but plan details must be prescribed based on the actual formulation and patient context.
How does IPS evaluate both injectable and oral options?
Yes. The current clinical program includes tirzepatide B6/B12 injectable considerations and oral tirzepatide tablet considerations. Who it may fit is reviewed during consultation.
Will I need a maintenance plan?
Yes. IPS treats maintenance as part of the program, with attention to protein, resistance training, sleep, habits, and follow-up after active weight-loss phases.
Clinical Positioning
Dual-incretin metabolic support.
Dual Incretin Signaling
Targets both GIP and GLP-1 pathways for appetite control, fullness, blood-sugar balance, and metabolic support.
Significant Weight-Management Support
Clinical trial data showed body-weight reductions up to 22.5% at the highest studied dose over 72 weeks.
Metabolic Health Support
Supports broader metabolic goals including glucose regulation, appetite control, cravings, portion control, and long-term weight-management planning.
Protocol Options
Available formulations and dosing pathways are selected based on the patient’s goals, tolerance, safety profile, and provider-directed plan.
Available Formats
Injectable first, oral when appropriate.
Tirzepatide is most commonly discussed as an injectable dual-incretin option. Oral tirzepatide options can be discussed for select patients, but route, expected benefit, candidacy, tolerance, and clinical fit are handled during consultation.
Why IPS is different
Not gray market. Not research-only. Not direct-to-consumer peptide kits.
Many consumers encounter products online labeled for research use only, not for human consumption, or laboratory chemicals. Those labels matter because they are not intended for patient care.
RESEARCH USE ONLYNOT FOR HUMAN CONSUMPTIONLABORATORY CHEMICALS
Products marketed online
- May be labeled research use only
- May be labeled not for human consumption
- May be marketed as laboratory chemicals
- May not include patient-specific documentation
- May not involve provider review
The IPS approach
- Consultation before recommendation
- Provider review
- Personalized recommendations
- Medical oversight
- Ongoing guidance and support
Important distinction
A product mixed at home from an online powder and labeled research use only is fundamentally different from care that begins with consultation, provider review, appropriate prescribing, and ongoing clinical guidance.
Annual Membership
Wholesale-Style Member Pricing
12-month IPS members receive access to preferred pricing on eligible peptide programs after consultation and medical review.
12-month membership requiredMember pricing reviewed during consultClinical review before any plan
Ask About Membership PricingContact
Ask IPS about tirzepatide eligibility.
Send your details and IPS can follow up about consultation scheduling and next steps.
Medical noteThis page is informational and is not intended to diagnose, treat, cure, or prevent disease. Medication decisions require qualified clinical care.